Pages that link to "Q35840623"

The following pages link to Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development. (Q35840623):

Displaying 17 items.

• Neuroimaging of dementia in 2013: what radiologists need to know (Q30654332) (← links)
• Serum metabolomic biomarkers of dementia (Q34042727) (← links)
• Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease (Q35946092) (← links)
• Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography (Q36265825) (← links)
• Molecular imaging as a guide for the treatment of central nervous system disorders (Q37262953) (← links)
• New treatment strategies for Alzheimer's disease: is there a hope? (Q37403383) (← links)
• Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography (Q37736746) (← links)
• Benefits and risks of add-on therapies for Alzheimer's disease (Q38620338) (← links)
• Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening (Q47111224) (← links)
• Advancing Drug Discovery and Development Using Molecular Imaging (ADDMI): an Interest Group of the World Molecular Imaging Society and an Inaugural Session on Positron Emission Tomography (PET). (Q48267766) (← links)
• (68)Ga based probe for Alzheimer's disease: synthesis and preclinical evaluation of homodimeric chalcone in β-amyloid imaging. (Q48608911) (← links)
• Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients (Q48628621) (← links)
• Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain. (Q52144701) (← links)
• Preclinical Comparison of the Amyloid-β Radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis. (Q53025487) (← links)
• Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451. (Q54965551) (← links)
• Tau PET imaging in neurodegenerative tauopathies-still a challenge (Q91011085) (← links)
• Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo (Q98463510) (← links)